CClinicalTrials.gg
CompletedNCT04417374HoCoPsyUpdated Jul 29, 2020

Caracteristics of the Patients Hospitalized With Unvonluntary Commitment Procedure, in the Context COVID-19

An observational study in COVID 19, Disease Outbreak and Mental Disorders, sponsored by University Hospital, Montpellier. Completed at 1 site in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2020-07-29.

Sponsored by University Hospital, Montpellier · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
94
Ages
18 Years and older
Sex
All
01

Study summary

The actual worldwide context (disease outbreak, confinements instaured in many countries) is a stressful factor for many people. It can have consequences on mental health : separation from loved ones, loss of freedom, uncertainty about infection status, boredom. Patients with mental disorders are especially vulnerable.

On march 17th, the french government ordonned a national confinement to slow the progression of the COVID-19 outbreak, for 15 days at first then renewed several times. This situation has led to a reorganization of care as requested on March 22nd, 2020 in the recommendations applicable to the organization of care in psychiatric services : priority to telephone contacts and teleconsultation by multiplying contacts and assessments.

By the time the reorganization of care became operational, the most vulnerable patients may have experienced a decompensation of their disease.

It is important to know if the COVID-19 outbreak combined with the confinement increased the number of unvoluntary commitment the month after the announce of the confinement.

This could help us understand which patients are more vulnerable is this context, and improve our organization (ambulatory and hospitalization care) if this situation occurs again.

Read the detailed description

The main objective is to notice if we can observe a increase in the number of unvonluntary commitment the month after the announce of the confinement in the psychiatric hospital La Colombière, CHU Montpellier, France.

Secondary objectives :

  • Describe the causes of unvonluntary commitment, and the principal psychiatric diagnostic of the patients
  • Assess the lengh of the hospitalization
  • Assess the number of patients hospitalized without psychiatric antecedent
  • Assess the number of treatment interruptions in the recent history before hospitalization
  • Asses the number of patients living alone
  • Asses the number of patients using drugs

It is expected to highlight :

  • An increase of the number of unvontuntary commitment
  • If one or several mental disorders were more at risk of requiring an unvonluntary commitment
  • An increased lengh of hospitalization
  • An increased number of unvonluntary commitment of patients without psychiatric antecedent
  • An increased number of treatment interruptions
  • A link between hospitalization and living alone
  • A link between hospitalization and using drugs

The medical file of all the patients unvonlutary commited from march 12th to April 09th 2020 are screened, and compared to the patients unvonlutary commited during the same period in 2019.

The caracteristics of interest are their age and sex, if the patient lives alone, the matter of hospitalization, its lengh, their primary psychiatric diagnostic, the use of toxics at the moment of the hospitalization and if this psychiatric decompensation happens in a context of treatment interruption.

02

Conditions studied

  • COVID 19
  • Disease Outbreak
  • Mental Disorders

Keywords

  • Confinement
  • Disease outbreak
  • Unvonluntary commitment
03

In context

COVID-19

7,640 studies on the registry are indexed under COVID-19; 488 are open to participants now.

This study's enrollment of 94 is below the median of 261 across 3,136 observational studies indexed under COVID-19.

Browse COVID-19 studies →

Lead sponsor

University Hospital, Montpellier is the lead sponsor of 1,244 studies on the registry; 225 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

Adults having been aditted to the psychiatric hospital La Colombière, CHU Montpellier, France, with unvonluntary commitment procedure from march 12th to April 09th (2019 and 2020)

Inclusion criteria

  • Unvonluntary commitment in psychiatric hospital La Colombière, CHU Montpellier, from march 12th to april 19th (2019 and 2020).

Exclusion criteria

Exclusion criteria:

  • refusal to participate
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
94 participants (actual)
Patient registry
No

Groups and cohorts

  • Unvonluntary commitment from March 12th to April 09th 2019

    Patients hospitalized with unvonluntary commitment procedure from March 12th to April 09th 2019

    Other: Description of groups caracteristics

  • Unvonluntary commitment from March 12th to April 09th 2020

    Patients hospitalized with unvonluntary commitment procedure from March 12th to April 09th 2020

    Other: Description of groups caracteristics

Interventions

  • OtherDescription of groups caracteristics

    Comparison of the two groups on all the following criterias : age, sex, if the patient lives alone, the matter of hospitalization, its lengh, their primary psychiatric diagnostic, the use of toxics at the moment of the hospitalization and if this psychiatric decompensation happens in a context of treatment interruption.

06

What researchers measure

Primary outcomes

  1. Number of hospitalized patients

    Number of hospitalized patients From March 12th to April 09th

    Time frame: 1 months

Secondary outcomes

  1. Cause of hospitalization

    Primary psychiatric diagnostic From March 12th to April 09th

    Time frame: 1 months

Other outcomes

  1. Lengh of hospitalization

    Patients without psychiatric antecedent (number) From March 12th to April 09th

    Time frame: 1 months

  2. Treatment interruption

    Presence of absence of history of treatment interruption leading to the hospitalization From March 12th to April 09th

    Time frame: 1 months

  3. Number of hospitalized patients living alone

    Number of hospitalized patients living alone (opposed to those living with family) From March 12th to April 09th

    Time frame: 1 months

  4. Use of drugs

    Number of patients using drugs From March 12th to April 09th

    Time frame: 1 months

07

Study locations

1 site
  • University hospital
    Montpellier, 34295, France
08

References and documents

Individual participant data

Plan to share: Undecided — NC

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 29, 2020, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04417374
Lead sponsor
University Hospital, Montpellier
Responsible party
Sponsor
First posted
Jun 4, 2020
Start date
May 1, 2020
Primary completion
May 30, 2020
Completion
Jun 30, 2020
Last update
Jul 29, 2020

Study contacts

Emilie Olie, MD PhD
principal investigator · University Hospital, Montpellier

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2020. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion